SCHEMBL308618

SCHEMBL308618

Nc1ccn([C@@H]2O[C@@H](CO[P@@](=O)(O)OP(=O)(O)O)[C@H](O)[C@H]2O)c(=O)n1

nearest known ligand 0.76

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
P2RY2 P41231 11/20 0.76
P2RY6 Q15077 14/20 0.72
P2RY4 P51582 7/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18785149 1.00 P2RY2 (0.76) P2RY2P2RY6P2RY4
SCHEMBL12595472 1.00 P2RY2 (0.76) P2RY2P2RY6P2RY4
SCHEMBL18785150 1.00 P2RY2 (0.76) P2RY2P2RY6P2RY4
SCHEMBL532547 1.00 P2RY2 (0.76) P2RY2P2RY6P2RY4
SCHEMBL154172 1.00 P2RY2 (0.76) P2RY2P2RY6P2RY4
SCHEMBL29360821 1.00 P2RY2 (0.76) P2RY2P2RY6P2RY4
SCHEMBL18785151 1.00 P2RY2 (0.76) P2RY2P2RY6P2RY4
SCHEMBL39904 1.00 P2RY2 (0.76) P2RY2P2RY6P2RY4
SCHEMBL10585778 0.99 P2RY2 (0.75) P2RY2P2RY6P2RY4
SCHEMBL22635992 0.99 P2RY2 (0.75) P2RY2P2RY6P2RY4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 393 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250215036-A1 METHOD FOR PRODUCING CYTIDINE-5'-DIPHOSPHATE COMPOUND KYOWA HAKKO BIO CO., LTD. (JP) 2025-07-03 US claimed
EP-4393934-A1 METHOD FOR PRODUCING CYTIDINE-5'-DIPHOSPHATE COMPOUND Kyowa Hakko Bio Co., Ltd. (JP) 2024-07-03 EP claimed
CN-117881685-A Process for producing cytidine-5' -biphosphoric acid compound 协和发酵生化株式会社 2024-04-12 CN claimed
US-11739357-B2 Recombinant microorganism for producing citicoline and method for producing citicoline SUZHOU BIOSYNTHETICA CO., LTD (CN) 2023-08-29 US claimed
EP-3650534-B1 RECOMBINANT MICROORGANISM FOR PRODUCING CYTIDINE DIPHOSPHATE AND METHOD FOR PRODUCING CYTIDINE DIPHOSPHATE SUZHOU BIOSYNTHETICA CO LTD (CN) 2023-03-15 EP claimed
WO-2023027178-A1 METHOD FOR PRODUCING CYTIDINE-5'-DIPHOSPHATE COMPOUND 協和発酵バイオ株式会社 2023-03-02 WO claimed
WO-2023026449-A1 METHOD FOR PRODUCING CYTIDINE 5'-DIPHOSPHATE COMPOUND 協和発酵バイオ株式会社 2023-03-02 WO claimed
CN-111635532-B Aggregation-induced fluorescence guest functionalized composite infinite coordination polymer nanoparticle and preparation and application thereof 华东师范大学 2021-07-27 CN claimed
CN-111635532-A Aggregation-induced fluorescence guest functionalized composite infinite coordination polymer nanoparticle and preparation and application thereof 华东师范大学 2020-09-08 CN claimed
EP-3527082-A1 DIETARY COMPLEMENT COMPOSITION Ingenius Biotech,S.L. (ES) 2019-08-21 EP claimed
US-20030027785-A1 Joint lubrication with P2Y purinergic receptor agonists INSPIRE PHARMACEUTICALS, INC. 2003-02-06 US claimed
WO-2003000056-A1 JOINT LUBRICATION WITH P2Y PURINERGIC RECEPTOR AGONISTS INSPIRE PHARMACEUTICALS, INC. (US) 2003-01-03 WO claimed
WO-2001077366-A1 POSITIVE SELECTION METHOD, COMPOUNDS, HOST CELLS AND USES THEREOF CUBIST PHARMACEUTICALS, INC. (US) 2001-10-18 WO claimed
EP-0432183-B1 NEW CITYDIN-5'-DIPHOSPHATE ALKANOLS AND GLYCEROLS, A PROCESS FOR PREPARING THEM AND THEIR USE HAFSLUND NYCOMED PHARMA (AT) 1993-10-27 EP claimed
EP-0470969-B1 PROCESS FOR THE SEPARATION AND PURIFICATION OF SIALYL TRANSFERASES ALBERTA RESEARCH COUNCIL (CA) 1993-08-04 EP claimed
EP-0470969-A1 PROCESS FOR THE SEPARATION AND PURIFICATION OF SIALYL TRANSFERASES. CHEMBIOMED LTD (CA) 1992-02-19 EP claimed
US-5059535-A PROCESS FOR THE SEPARATION AND PURIFICATION OF SIALYL TRANSFERASES CHEMBIOMED, LTD. (CA) 1991-10-22 US claimed
WO-1990012090-A1 PROCESS FOR THE SEPARATION AND PURIFICATION OF SIALYL TRANSFERASES CHEMBIOMED LTD. (CA) 1990-10-18 WO claimed
US-4577012-A ABSORPTION ON ACTIVATED CARBON, ELUTION WITH ALKALI HYDROXIDE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1986-03-18 US claimed
US-RE28886-E Method for preparing cytidine diphosphate choline KYOWA HAKKO KOGYO CO., LTD. (JA) 1976-06-29 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250215036-A1 METHOD FOR PRODUCING CYTIDINE-5'-DIPHOSPHATE COMPOUND NUDT1, ENTPD5, ITPA P2RY2 62/4885P2RY6 35/4885P2RY4 50/4885
US-20030027785-A1 Joint lubrication with P2Y purinergic receptor agonists P2RY1, P2RY2, P2RY6 P2RY2 2/4885P2RY6 3/4885P2RY4 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.